Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-5,550
Closed -$398K 1271
2021
Q4
$398K Buy
+5,550
New +$422K ﹤0.01% 1076
2018
Q4
Sell
-2,976
Closed -$303K 784
2018
Q3
$303K Buy
+2,976
New +$287K ﹤0.01% 686
2017
Q4
Sell
-5,999
Closed -$375K 1062
2017
Q3
$375K Buy
+5,999
New +$355K ﹤0.01% 802
2017
Q2
Sell
-4,643
Closed -$283K 939
2017
Q1
$283K Buy
4,643
+34
+0.7% +$1.92K ﹤0.01% 729
2016
Q4
$253K Buy
+4,609
New +$221K ﹤0.01% 710
2016
Q3
Sell
-15,402
Closed -$524K 561
2016
Q2
$524K Buy
+15,402
New +$481K 0.01% 318

Other funds holding NGVT

Natixis's NGVT Position: Q1 2022 in Review

Natixis sold out of Ingevity (NGVT) in Q1 2022, closing a stake of 5,550 shares — an estimated $398K sold.

Natixis first reported a position in NGVT in Q2 2016 and held it in 6 quarters. The position peaked at $524K in Q2 2016. 274 funds tracked by Wall St. Rank hold NGVT as of Q1 2022.

  • Natixis reported no remaining Ingevity position as of Q1 2022 after selling out during the quarter.
  • Natixis sold 5,550 Ingevity shares in Q1 2022, an estimated $398K.
  • Natixis first reported a position in Ingevity in Q2 2016 and held it in 6 quarters.
  • Natixis's Ingevity position peaked at $524K in Q2 2016.
  • 274 funds tracked by Wall St. Rank held Ingevity as of Q1 2022.

Based on Natixis's 13F filing for Q1 2022, filed 13 May 2022.